BBIO

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BridgeBio Pharma Inc

NASDAQ | BBIO

72.00

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$13.88B

Market Cap

-

P/E Ratio

-4.21

EPS

$72.28

52 Week High

$25.34

52 Week Low

HEALTHCARE

Sector

BBIO Chart

Recent Chart
Price Action

BBIO Technicals

Tags:

BBIO Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $218M
Total Revenue $222M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income -$593M
Selling General And Administrative $251M
Research And Development $506M
Operating Expenses $811M
Investment Income Net -
Net Interest Income -$82M
Interest Income $17M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.1M
Income Before Tax -$542M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$543M
Comprehensive Income Net Of Tax -
Ebit -$443M
Ebitda -$437M
Net Income -$536M

Revenue & Profitability

Earnings Performance

BBIO Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $919M
Total Current Assets $721M
Cash And Cash Equivalents At Carrying Value $681M
Cash And Short Term Investments $681M
Inventory -
Current Net Receivables $4.7M
Total Non Current Assets $199M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $24M
Intangible Assets Excluding Goodwill $24M
Goodwill -
Investments -
Long Term Investments $144M
Short Term Investments $0
Other Current Assets $35M
Other Non Current Assets -
Total Liabilities $2.4B
Total Current Liabilities $154M
Current Accounts Payable $9.6M
Deferred Revenue -
Current Debt -
Short Term Debt $4.5M
Total Non Current Liabilities $2.2B
Capital Lease Obligations $9.2M
Long Term Debt $1.7B
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.7B
Other Current Liabilities $140M
Other Non Current Liabilities $286K
Total Shareholder Equity -$1.5B
Treasury Stock -
Retained Earnings -$3.1B
Common Stock $196K
Common Stock Shares Outstanding $186M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$521M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $6.1M
Capital Expenditures $933K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $61M
Cashflow From Financing $748M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$7.5M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$543M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $218M
Total Revenue $222M
Cost Of Revenue $3.9M
Costof Goods And Services Sold $3.9M
Operating Income -$593M
Selling General And Administrative $251M
Research And Development $506M
Operating Expenses $811M
Investment Income Net -
Net Interest Income -$82M
Interest Income $17M
Interest Expense $99M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $6.1M
Income Before Tax -$542M
Income Tax Expense $1.2M
Interest And Debt Expense -
Net Income From Continuing Operations -$543M
Comprehensive Income Net Of Tax -
Ebit -$443M
Ebitda -$437M
Net Income -$536M

BBIO News

BBIO Profile

BridgeBio Pharma Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BridgeBio Pharma, Inc. is a leading biopharmaceutical company based in Palo Alto, California, focusing on the discovery, development, and commercialization of innovative therapies for genetic diseases and rare disorders. With a robust pipeline and a commitment to addressing critical unmet medical needs, BridgeBio employs advanced scientific methodologies to create transformative treatments. The company’s dedication to improving patient outcomes positions it as a formidable player in the genetic medicine space, with a vision to redefine care standards for underserved patient populations.

LPTX
+368.57%
$2.05
DRCT
+15.27%
$0.13
QTTB
+128.77%
$5.01
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
NVDA
+1.32%
$179.34
AXDX
-61.36%
$0.03
KALA
+36.77%
$1.32
IVP
-0.24%
$0.12
FTEL
+53.00%
$1.30
ADAP
-15.14%
$0.05
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
ASST
-8.92%
$1.02
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
CHR
+7.46%
$0.04
BURU
-4.91%
$0.23
BITF
-7.90%
$3.20
INTC
-1.59%
$39.91
SRM
+53.27%
$10.30
CNEY
-15.45%
$1.23
RPGL
+9.35%
$0.44
AHMA
+197.75%
$14.32
NFE
+17.62%
$1.43
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
BMNR
-9.93%
$29.83
TSLA
-0.70%
$427.12
BMNU
-24.25%
$6.20
PLUG
-4.44%
$1.92
NIO
-5.64%
$5.18
ONDS
-3.35%
$7.63
YGMZ
+3.32%
$0.11
TLRY
-3.59%
$0.78
BTG
+3.35%
$4.62
AFMD
-34.94%
$0.18
AAL
-0.08%
$14.03
CLSK
-5.32%
$14.29
BYND
+0.20%
$0.98
MARA
-8.32%
$10.82
SOFI
-0.76%
$29.49
SNAP
-1.93%
$7.53
NWTN
-9.09%
$0.70
GRYP
-10.38%
$1.38
INHD
-15.65%
$0.18
MODV
-25.22%
$0.43
NCT
-36.96%
$0.48
PRPH
-20.29%
$0.16
PLTR
+1.61%
$168.45
F
+0.59%
$13.35
VHAI
-25.00%
$0.00
CAN
-8.15%
$0.92
SAND
-6.04%
$12.12
CIFR
-3.43%
$19.65
GOOGL
-1.28%
$316.05
SHOT
-74.37%
$0.39
AMD
-0.08%
$217.35
ZAPP
-46.30%
$0.15
AMZN
+0.12%
$233.50
PFE
-0.04%
$25.72
WBUY
+39.26%
$2.20
HOOD
+0.22%
$128.49
RIVN
+2.10%
$17.21
RUBI
-15.28%
$0.13
WULF
-3.64%
$14.94
MSTR
-12.01%
$155.90
ACHR
-4.89%
$7.40
SOUN
+1.94%
$12.05
AG
+3.15%
$15.71
CPNG
-4.77%
$26.81
GPUS
-8.53%
$0.27
ITUB
-1.15%
$7.71
IREN
-4.12%
$45.84
BTBT
-8.54%
$2.17
DEFT
-11.17%
$1.35
BBD
-0.94%
$3.66
RIG
+0.90%
$4.45
EXK
-4.48%
$9.48
IBRX
-0.84%
$2.34
RGTI
-6.31%
$23.95
DVLT
-9.32%
$1.84
GRAB
-2.20%
$5.33
SKYQ
-1.45%
$0.34
BAC
-0.18%
$53.55
TEVA
+2.16%
$26.89
AMZE
+4.79%
$0.50
CRWV
+0.95%
$73.82
TE
+6.60%
$4.39
GOOG
-0.74%
$317.75
KDLY
+0.36%
$0.50
NVVE
-19.75%
$0.18
SMR
-8.12%
$18.37
DNN
-0.58%
$2.54
AAPL
-0.18%
$278.32
SMCI
-2.54%
$32.99
CRCL
-4.83%
$76.06
VSA
-5.88%
$0.10
LPTX
+368.57%
$2.05
DRCT
+15.27%
$0.13
QTTB
+128.77%
$5.01
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
NVDA
+1.32%
$179.34
AXDX
-61.36%
$0.03
KALA
+36.77%
$1.32
IVP
-0.24%
$0.12
FTEL
+53.00%
$1.30
ADAP
-15.14%
$0.05
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
ASST
-8.92%
$1.02
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
CHR
+7.46%
$0.04
BURU
-4.91%
$0.23
BITF
-7.90%
$3.20
INTC
-1.59%
$39.91
SRM
+53.27%
$10.30
CNEY
-15.45%
$1.23
RPGL
+9.35%
$0.44
AHMA
+197.75%
$14.32
NFE
+17.62%
$1.43
WLGS
-5.57%
$0.04
MTSR
-0.35%
$70.50
BMNR
-9.93%
$29.83
TSLA
-0.70%
$427.12
BMNU
-24.25%
$6.20
PLUG
-4.44%
$1.92
NIO
-5.64%
$5.18
ONDS
-3.35%
$7.63
YGMZ
+3.32%
$0.11
TLRY
-3.59%
$0.78
BTG
+3.35%
$4.62
AFMD
-34.94%
$0.18
AAL
-0.08%
$14.03
CLSK
-5.32%
$14.29
BYND
+0.20%
$0.98
MARA
-8.32%
$10.82
SOFI
-0.76%
$29.49
SNAP
-1.93%
$7.53
NWTN
-9.09%
$0.70
GRYP
-10.38%
$1.38
INHD
-15.65%
$0.18
MODV
-25.22%
$0.43
NCT
-36.96%
$0.48
PRPH
-20.29%
$0.16
PLTR
+1.61%
$168.45
F
+0.59%
$13.35
VHAI
-25.00%
$0.00
CAN
-8.15%
$0.92
SAND
-6.04%
$12.12
CIFR
-3.43%
$19.65
GOOGL
-1.28%
$316.05
SHOT
-74.37%
$0.39
AMD
-0.08%
$217.35
ZAPP
-46.30%
$0.15
AMZN
+0.12%
$233.50
PFE
-0.04%
$25.72
WBUY
+39.26%
$2.20
HOOD
+0.22%
$128.49
RIVN
+2.10%
$17.21
RUBI
-15.28%
$0.13
WULF
-3.64%
$14.94
MSTR
-12.01%
$155.90
ACHR
-4.89%
$7.40
SOUN
+1.94%
$12.05
AG
+3.15%
$15.71
CPNG
-4.77%
$26.81
GPUS
-8.53%
$0.27
ITUB
-1.15%
$7.71
IREN
-4.12%
$45.84
BTBT
-8.54%
$2.17
DEFT
-11.17%
$1.35
BBD
-0.94%
$3.66
RIG
+0.90%
$4.45
EXK
-4.48%
$9.48
IBRX
-0.84%
$2.34
RGTI
-6.31%
$23.95
DVLT
-9.32%
$1.84
GRAB
-2.20%
$5.33
SKYQ
-1.45%
$0.34
BAC
-0.18%
$53.55
TEVA
+2.16%
$26.89
AMZE
+4.79%
$0.50
CRWV
+0.95%
$73.82
TE
+6.60%
$4.39
GOOG
-0.74%
$317.75
KDLY
+0.36%
$0.50
NVVE
-19.75%
$0.18
SMR
-8.12%
$18.37
DNN
-0.58%
$2.54
AAPL
-0.18%
$278.32
SMCI
-2.54%
$32.99
CRCL
-4.83%
$76.06
VSA
-5.88%
$0.10
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.